MARKET

OSTX

OSTX

OS THERAPIES INCORPORATED
AMEX
1.260
-0.040
-3.08%
After Hours: 1.300 +0.04 +3.17% 19:11 02/10 EST
OPEN
1.300
PREV CLOSE
1.300
HIGH
1.310
LOW
1.240
VOLUME
425.75K
TURNOVER
--
52 WEEK HIGH
2.980
52 WEEK LOW
1.120
MARKET CAP
44.37M
P/E (TTM)
-1.2866
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OSTX last week (0202-0206)?
Weekly Report · 1d ago
OS Therapies Is Maintained at Buy by D. Boral Capital
Dow Jones · 5d ago
OS Therapies Price Target Maintained With a $20.00/Share by D. Boral Capital
Dow Jones · 5d ago
D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target
Benzinga · 5d ago
OS Therapies Applauds Reauthorization of Pediatric Priority Review Voucher Program to Advance Breakthrough Osteosarcoma Immunotherapies
Newsfile · 6d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 6d ago
OS Therapies Begins FDA Filing for Experimental Cancer Treatment Aimed at Osteosarcoma Recurrence
Benzinga · 02/02 11:02
OS Therapies Initiates US FDA BLA Filing for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
Newsfile · 02/02 11:00
More
About OSTX
OS Therapies Incorporated is a clinical-stage oncology company focused on the identification, development, and commercialization of new class immunotherapy candidates for solid tumors, beginning with osteosarcoma and other solid tumors. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. Its lead asset, OST-HER2, is an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria monocytogenes, a species of bacteria that causes the infection listeriosis, that expresses HER2 peptides. OST-tADC is a tunable ADC with a plug-and-play platform that features tunable pH-sensitive silicone linkers (SiLinkers). Its clinical-stage cancer immunotherapy programs also include OST-AXAL for human papilloma virus (HPV)-associated cancers; OST-503 for non-small cell lung cancer (NSCLC) & glioblastoma; and OST-PSA for prostate cancer.

Webull offers OS Therapies Inc stock information, including AMEX: OSTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OSTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OSTX stock methods without spending real money on the virtual paper trading platform.